MECP2 and Beyond: Phenotype—Genotype Correlations in Rett Syndrome

Abstract

The association of Rett syndrome with pathogenic mutations of the methyl-CpG binding protein 2 ( MECP2) gene was first made in 1999. Since that time, it has been found that the clinical phenotype can, at least in part, be explained in terms of the type and location of the MECP2 mutation and epigenetic factors such as skewing of X-chromosome inactivation. In addition, MECP2 mutations may be associated with non—Rett syndrome clinical phenotypes, including nonsyndromic and syndromic X-linked mental retardation and Angelman-like phenotypes. Intense research efforts are currently focused on understanding the pathogenesis of Rett syndrome, using sophisticated techniques such as microarray analysis, and the development of mouse models, with an ultimate aim being the development of targeted therapies that could ameliorate or even prevent the devastating consequences of this enigmatic neurodevelopmental disorder. (J Child Neurol 2003;18:669—674).

Get full access to this article

View all access options for this article.

References

Leonard H. , Bower C. , English D. : The prevalence and incidence of Rett syndrome in Australia. Eur Child Adolesc Psychiatry 1997;6(Suppl):S8—S10.

Hagberg B. , Goutiéres F. , Hanefield F. , et al: Rett syndrome: Criteria for inclusion and exclusion. Brain Dev 1985;7:372—373.

Ellaway CJ , Williams K. , Leonard H. , et al: Rett syndrome: Randomised controlled trial of L-carnitine. J Child Neurol 1999; 14:162—167.

Trevathan E. , Moser HW (Rett Syndrome Working Group): Diagnostic criteria for Rett syndrome. Ann Neurol 1988 ;23:425—428.

Goutiéres F. , Aicardi J. : New experience with Rett syndrome in France: The problem of atypical cases. Brain Dev 1987 ;9:502—505.

Hagberg B. , Witt-Engerstrom I. : Rett syndrome: Epidemiology and nosology—Progress in knowledge 1986A conference communication. Brain Dev 1987;9:451—457.

Percy AK , Zoghbi HY , Glaze DG : Rett syndrome: Discrimination of typical and variant forms. Brain Dev 1987;9:458—461.

Hagberg BA , Skjeldal OH : Rett variants: A suggested model for inclusion criteria. Pediatr Neurol 1994; 11: 5—11.

Zappella M. : The Rett girls with preserved speech. Brain Dev 1992;14:98—101.

10.

Naidu S. , Bibat G. , Kratz L. , et al: Clinical variability in Rett syndrome. J Child Neurol 2003;18:662—668.

11.

Hagberg B. , Aicardi J. , Dias K. , et al: A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: Report of 35 cases. Ann Neurol 1983;14:471—479.

12.

Armstrong DD : Review of Rett syndrome. J Neuropathol Exp Neurol 1997;56:843—849.

13.

Ellaway CJ , Peat J. , Williams K. , et al: Medium-term open label trial of L-carnitine in Rett syndrome . Brain Dev 2001;23(Suppl 1): S85—S89.

14.

Percy AK : Clinical trials and treatment prospects. Mental Retard Dev Disabil Res Rev 2002;8:106—111.

15.

Journel H. , Melki J. , Turleau C. , et al: Rett phenotype with X/autosome translocation: Possible mapping to the short arm of chromosome X. Am J Med Genet 1990;35:142—147.

16.

Zoghbi HY , Ledbetter DH , Schultz R. , et al: A de novo X;3 translocation in Rett syndrome. Am J Med Genet 1990;35:148—151.

17.

Delobel B. , Delannoy V. , Pini G. , et al: Identification and molecular characterisation of a small 11q23.3 de novo duplication in a patient with Rett syndrome manifestations. Am J Med Genet 1998;80: 273—280.

18.

Gustavsson P. , Kimber E. , Wahlstrom J. , et al: Monosomy 18q syndrome and atypical Rett syndrome in a girl with an interstitial deletion (18)(q21.1q22.3). Am J Med Genet 1999;82:348—351.

19.

Wahlström J. , Uller A. , Johannesson T. , et al: Congenital variant Rett syndrome in a girl with terminal deletion of chromosome 3p. J Med Genet 1999;36:343—345.

20.

Tang J. , Qi Y. , Bao XH , et al: Mutational analysis of mitochondrial DNA of children with Rett syndrome. Pediatr Neurol 1997; 17:327—330.

21.

Ellaway CJ , McQuade LR , Christodoulou J. : Novel mitochondrial 16S rRNA polymorphism in a girl with Rett syndrome. J Inherit Metab Dis 1999;22:946—947.

22.

Ellison KA , Fill CP , Terwilliger J. , et al: Examination of X chromosome markers in Rett syndrome: Exclusion mapping with a novel variation on multilocus linkage analysis. Am J Hum Genet 1992;50:278—287.

23.

Curtis A. , Headland S. , Lindsay S. , et al: X chromosome linkage studies in familial Rett syndrome. Hum Genet 1993;90:551—555.

24.

Schanen NC , Dahle EJ , Capozzoli F. , et al: A new Rett syndrome family consistent with X-linked inheritance expands the X chromosome exclusion map. Am J Hum Genet 1997;61:634—641.

25.

Schanen C. , Francke U. : A severely affected male born into a Rett syndrome kindred supports X-linked inheritance and allows extension of the exclusion map. Am J Hum Genet 1998;63:267—269.

26.

Sirianni N. , Naidu S. , Pereira J. , et al: Rett syndrome: Confirmation of X-linked dominant inheritance, and localisation of the gene to Xq28 [letter]. Am J Hum Genet 1998;63:1552—1558.

27.

Amir RE , van den Veyver IB , Wan M. , et al: Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999 ;23:185—188.

28.

Nan X. , Meehan RR , Bird A. : Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2 . Nucleic Acid Res 1993;21:4886—4892.

29.

Nan X. , Campoy FJ , Bird A. : MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 1997; 88:471—481.

30.

Jones PL , Veenstra Gjc , Wade PA , et al: Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 1998;19:187—191.

31.

Nan X. , Ng H-H. , Johnson CA , et al: Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 1998;393:386—389.

32.

Kokura K. , Kaul SC , Wadhwa R. , et al: The Ski protein family is required for MeCP2-mediated transcriptional repression . J Biol Chem 2001;276:34115—34121.

33.

Yu F. , Thiesen J. , Strätling WH : Histone deacetylase-independent transcriptional repression by methyl-CpG-binding protein 2. Nucleic Acid Res 2001;28:2201—2206.

34.

Hoffbuhr KC , Moses LM , Jerdonek MA , et al: Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype. Mental Retard Dev Disabil Res Rev 2002;8:99—105.

35.

Christodoulou J. , Grimm A. , Maher T. , et al: RettBASE: The IRSA MECP2 Variation Database. A new mutation database in evolution. Hum Mut 2003;31(6):466—472.

36.

Nielsen JB , Henriksen KF , Hansen C. , et al: MECP2 mutations in Danish patients with Rett syndrome: High frequency of mutations but no consistent correlations with clinical severity or with the X chromosome inactivation pattern. Eur J Hum Genet 2001 ;9:178—184.

37.

Bourdon V. , Philippe C. , Labrune O. , et al: A detailed analysis of the MECP2 gene: Prevalence of recurrent mutations and gross DNA rearrangements in Rett syndrome patients. Hum Genet 2001;108:43—50.

38.

Wan MM , Lee Ssj , Zhang XY , et al: Rett syndrome and beyond: Recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet 1999;65:1520—1529.

39.

Thomas GH : High male:female ratio of germ-line mutations: An alternative explanation for postulated gestational lethality in males with X-linked dominant disorders . Am J Hum Genet 1996;58:1364—1368.

40.

Girard M. , Couvert P. , Carrié A. , et al: Parental origin of de novo MECP2 mutations in Rett syndrome . Eur J Hum Genet 2001; 9:231—236.

41.

Trappe R. , Laccone F. , Cobilanschi J. , et al: MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. Am J Hum Genet 2001;68:1093—1101.

42.

Meehan RR , Lewis JD , McKay S. , et al: Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell 1989 ;58:499—507.

43.

Lewis JD , Meehan RR , Henzel WJ , et al: Purification, sequence, and cellular localisation of a novel chromosomal protein that binds to methylated DNA. Cell 1992;69:905—914.

44.

Nan X. , Cross S. , Bird A. : Gene silencing by methyl-CpG-binding proteins. Epigenetics. Novartis Foundation Symposium, vol 214. Wiley, Chichester, UK, 1998, 6—21.

45.

Goutiéres F. , Aicardi J. : Atypical forms of Rett syndrome. Am J Med Genet 1986;24 (Suppl 1):183—194.

46.

Skjeldal OH , von Tetzchner S. , Jacobsen K. , et al: Rett syndrome— Distribution of phenotypes with special attention to the preserved speech variant. Neuropediatrics 1995;26:87.

47.

Weaving LS , Williamson SL , Bennetts B. , et al: Effects of MECP2 mutation type, location and X-inactivation in modulating Rett syndrome phenotype. Am J Med Genet 2003;118A:103—114.

48.

Cheadle JP , Gill H. , Fleming N. , et al: Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: Correlation of disease severity with mutation type and location . Hum Mol Genet 2000;9:1119—1129.

49.

Huppke P. , Laccone F. , Kramer N. , et al: Rett syndrome: Analysis of MECP2 and clinical characterisation of 31 patients. Hum Mol Genet 2000;9:1369—1375.

50.

Hoffbuhr K. , Devaney JM , LaFleur B. , et al: MECP2 mutations in children with and without the phenotype of Rett syndrome. Neurology 2001;56:1486—1495.

51.

Zoghbi HY , Percy AK , Schultz RJ , et al: Patterns of X chromosome inactivation in the Rett syndrome. Brain Dev 1990;12:131—135.

52.

Bienvenu T. , Carrié A. , De Roux N. , et al: MECP2 mutations account for most cases of typical forms of Rett syndrome. Hum Mol Genet 2000;9:1377—1384.

53.

Amir RE , Van den Veyver IB , Schultz R. , et al: Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes. Ann Neurol 2000;47:670—679.

54.

Ishii T. , Makita Y. , Ogawa A. , et al: The role of different X-inactivation patterns on the variable clinical phenotype with Rett syndrome. Brain Dev 2001;23(Suppl 1):S161—S164.

55.

van den Veyver IB , Zoghbi HY : Methyl-CpG-binding protein 2 mutations in Rett syndrome. Curr Opin Genet Dev 2000;10: 275—279.

56.

Schwartzman JS , Bernardino A. , Nishimura A. , et al: Rett syndrome in a boy with a 47,XXY karyotype confirmed by a rare mutation in the MECP2 gene. Neuropediatrics 2001;32:162—164.

57.

Villard L. , Kpebe A. , Cardoso C. , et al: Two affected boys in a Rett syndrome family—Clinical and molecular findings. Neurology 2000;55:1188—1193.

58.

Clayton-Smith J. , Watson P. , Ramsden S. , et al: Somatic mutation in MECP2 as a nonfatal neurodevelopmental disorder in males. Lancet 2000;356:830—832.

59.

Orrico A. , Lam C-W. , Galli L. , et al: MECP2 mutation in male patients with nonspecific X-linked mental retardation. FEBS Lett 2000;481:285—288.

60.

Yntema HG , Kleefstra T. , Oudakker AR , et al: Low frequency of MECP2 mutations in mentally retarded males . Eur J Hum Genet 2002;10:487—490.

61.

Meloni I. , Bruttini M. , Longo I. , et al: A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. Am J Hum Genet 2000;67:982—985.

62.

Klauck SM , Lindsay S. , Beyer KS , et al: A mutation hot spot for nonspecific X-linked mental retardation in the MECP2 gene causes the PPM-X syndrome. Am J Hum Genet 2002;70:1034—1037.

63.

Watson P. , Black G. , Ramsden S. , et al: Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J Med Genet 2001;38:224—228.

64.

Vourc'h P. , Bienvenu T. , Beldjord C. , et al: No mutations in the coding region of the Rett syndrome gene MECP2 in 59 autistic patients. Eur J Hum Genet 2001;9:556—558.

65.

Beyer KS , Blasi F. , Bacchelli E. , et al: Mutation analysis of the coding sequence of the MECP2 gene in infantile autism. Hum Genet 2002;111:305—309.

66.

Lobo-Menendez F. , Sossey-Alaoui K. , Bell JM , et al: Absence of MECP2 mutations in patients from the South Carolina autism project. Am J Med Genet 2003;117B:97—101.

67.

Laccone F. , Zoll B. , Huppke P. , et al: MECP2 gene nucleotide changes and their pathogenicity in males: Proceed with caution. J Med Genet 2002;39:586—588.

68.

Imessaoudene B. , Bonnefont JP , Royer G. , et al: MECP2 mutation in non-fatal, non-progressive encephalopathy in a male. J Med Genet 2001 ;38:171—174.

69.

Kudo S. , Nomura Y. , Segawa M. , et al: Functional analyses of MECP2 mutations associated with Rett syndrome using transient expression systems. Brain Dev 2001;23(Suppl 1):S165—S173.

70.

Chen RZ , Akbarian S. , Tudor M. , et al: Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 2001;27:327—331.

71.

Guy J. , Hendrich B. , Holmes M. , et al: A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 2001;27:322—326.

72.

Shahbazian M. , Young J. , Yuva-Paylor L. , et al: Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 2002;35:243—254.

73.

Colantuoni C. , Jeon OH , Hyder K. , et al: Gene expression profiling in postmortem Rett syndrome brain: Differential gene expression and patient classification . Neurobiol Dis 2001;8:847—865.

74.

Tudor M. , Akbarian S. , Chen RZ , et al: Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc Natl Acad Sci U S A 2002;99: 15536—15541.

75.

Vacca M. , Filippini F. , Budillon A. , et al: Mutation analysis of the MECP2 gene in British and Italian Rett syndrome females. J Mol Med 2001;78:648—655.